🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The objective of this study is to evaluate the safety and tolerability of m...
Status
Completed
Location
Closed information
Start Date
2017-04-10
Trial ID
NCT03096223
Treatments Being Tested
The primary objective of the study is to evaluate the pharmacokinetics of r...
Status
Completed
Location
Huashan Hospital Affiliated to Fudan University?
Start Date
2024-01-23
Trial ID
NCT06214481
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2022-05-31
Trial ID
NCT05398445
Treatments Being Tested
The primary objective of this study is to describe the long-term safety and...
Status
Terminated
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-05-31
Trial ID
NCT05882877
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of ad...
Status
Completed
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02647866
The primary objectives of this study are to: * estimate vaccine response i...
Status
Completed
Location
Affiliated Dermatology
Start Date
2023-06-07
Trial ID
NCT05899816
Treatments Being Tested
The co-primary objectives of the study are to: * Evaluate the efficacy of ...
Status
Completed
Location
Research Solutions of Arizona, PC
Start Date
2022-12-14
Trial ID
NCT05651711
Treatments Being Tested
The primary objective of this study is to describe the efficacy of rocatinl...
Status
Terminated
Location
Kern Research Inc
Start Date
2024-05-24
Trial ID
NCT06376045
Treatments Being Tested